Steroids in immunologically mediated renal disease.
Pulse steroid regimens, early tapering to alternate-day treatment, and careful use of supplemental immunosuppression with cytotoxic drugs offer strategies for improving the therapeutic index of corticosteroid management.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D019867:Anti-Glomerular Basement Membrane Disease / Q000188:drug therapy / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000032:analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000145:classification / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy* / Q000276:immunology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D009393:Nephritis / Q000188:drug therapy / Q000276:immunology; D009402:Nephrosis, Lipoid / Q000188:drug therapy / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000936:Antigen-Antibody Complex; D000970:Antineoplastic Agents